TELUS has engaged TD Securities and Jefferies to advise on monetizing TELUS Health, a fast-growing digital health business reaching 160 million lives across more than 200 countries. The move may include strategic partnerships as TELUS seeks value creation and balance-sheet deleveraging.
As of Q3 2025, TELUS Health generated $1.5 billion in revenue, $258 million EBITDA, and $99 million cash flow. CEO Darren Entwistle called the unit a world-class Canadian asset with expanding AI capabilities. Monetization supports debt reduction targets toward three-times leverage by 2027, reinforcing TELUS’ disciplined capital allocation strategy.
Want to know more? Check out the source code here.